earnings
confidence high
sentiment positive
materiality 0.85
Select Medical Q2 revenue up 5.1% to $1.76B, EPS $0.60; Concentra IPO raises $528.8M
SELECT MEDICAL HOLDINGS CORP
2024-Q2 EPS reported
$1.35
revenue$3,548,472,000
- Q2 rev $1,759.7M (+5.1% YoY), net income $94.8M (+3.2%), GAAP EPS $0.60 vs $0.61 prior.
- Adj EBITDA $226.3M (+3.1%); FY2024 guidance reaffirmed (rev $6.9-7.1B, adj EPS $1.96-2.20).
- Concentra IPO raised $528.8M (22.5M shares at $23.50); also issued $650M 6.875% Senior Notes due 2032.
- IPO & debt proceeds repaid $1.9B of Select credit facilities; $0.125/shr dividend declared.